Home » World Health Organization (WHO) » Page 14

World Health Organization (WHO)

CND Intersessional Meeting – 10 October: Operational recommendations on Ensuring the availability of and access to controlled substances exclusively for medical and scientific purposes, while preventing their diversion

Gilberto Gerra, UNODC: There is a clear imbalance in terms of access to essential medicines. The UNGASS outcome document contemplates measures to facilitate this. Ethical mandate to reduce burden of pain. Countries have produced a myriad of supplementary regulations that restrict access and go beyond international obligations: burdensome registration of patients, specific permissions for doctors, …

Read more

CND Intersessional Meeting – 10 October: Operational recommendations on Demand reduction and related measures, including prevention and treatment, as well as other health-related issues

CND Chair: I propose that we tackle the more logistical agenda items 2 and 3 first, before moving onto the thematic discussions (agenda item 1). Agenda item 2 – plans for the reconvened 59th CND (December) and the 60th CND (March). New nominees have been put forward for 2nd Vice-Chair (Brazil) and 3rd Vice-Chair (Nigeria). …

Read more

Side event: Addressing global disparities in access to controlled substances for medical purposes, with focus on treatment and pain relief

Organised by the Governments of Australia, Belgium, Ghana, Norway and Panama, the International Narcotics Control Board, the World Health Organisation, the United Nations Office on Drugs and Crime and the International Union Against Cancer. The Hon. Ken Wyatt AM, Assistant Minister for Health and Aged Care, Government of Australia (Chair) 5.5 billion people do not …

Read more